312 results
8-K
SAVA
Cassava Sciences Inc
22 May 24
Departure of Directors or Certain Officers
4:58pm
employment benefits, for a period of 12 months following his last date of employment with the Company.
The foregoing description is only a summary
8-K
EX-10.1
SAVA
Cassava Sciences Inc
22 May 24
Departure of Directors or Certain Officers
4:58pm
a “Change in Control” (as defined herein) you will be paid your regular base salary, and you will continue to receive employment benefits, for a period
8-K
EX-99.1
SAVA
Cassava Sciences Inc
10 May 24
Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam
4:07pm
employees regarding simufilam, drug effects, and the treatment of Alzheimer’s disease; and potential benefits, if any, of our product candidates … the specificity, safety, efficacy or potential health benefits of our product candidates, the apparent ability of simufilam to favor patients with mild
8-K
EX-99.1
SAVA
Cassava Sciences Inc
1 May 24
Other Events
9:13am
; comments made by our employees regarding the warrant distribution, simufilam, and potential benefits, if any, of our product candidates … studies on expected timelines, to demonstrate the specificity, safety, efficacy or potential health benefits of our product candidates, any
8-K
EX-99.1
n9x8mt5f2ognjf 7d
15 Apr 24
Redemption Date Announced for Warrants
4:01pm
8-K
EX-99.1
45vbo4lto0vevfozarbi
28 Feb 24
Cassava Sciences Reports Full-year 2023 Financial Results and Corporate Updates
9:22am
8-K
EX-99.1
a6ndnbmvn1d twh
7 Feb 24
No Decline in Cognition Scores in Patients with Mild Alzheimer's Disease Who Received Simufilam Continuously For 24 Months
9:20am
424B2
ixtzxyishhjf9
3 Jan 24
Prospectus for primary offering
4:22pm
8-A12B
EX-4.1
yvbf2xf 72511jxpkk
3 Jan 24
Registration of securities on exchange
4:18pm
8-K
gg6hvgwiq
3 Jan 24
Entry into a Material Definitive Agreement
9:10am
8-K
EX-4.1
pd4p gr5c
3 Jan 24
Entry into a Material Definitive Agreement
9:10am
8-A12G
EX-4.1
lbuh2537l jhldzy
2 Jan 24
Registration of securities
9:10am
8-K
EX-99.1
tdi95dnqu lko01bsqpq
12 Dec 23
Cassava Sciences Announces Dividend Distribution of Warrants to Shareholders
9:19am
8-K
EX-99.2
866xzs3iyvyvq3pps57l
12 Dec 23
Cassava Sciences Announces Dividend Distribution of Warrants to Shareholders
9:19am
8-K
c2dvxp9
12 Dec 23
Cassava Sciences Announces Dividend Distribution of Warrants to Shareholders
9:19am